Ritalin LA
NDC 0078-0371, methylphenidate hydrochloride, capsule, extended release, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0371
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021284
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYLPHENIDATE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/effd952d-ac94-47bb-b107-589a4934dcca
Use it
Look up 0078-0371 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0371 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0371. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.